Zynex Inc is engaged in the manufacturing and marketing of medical devices... Show more
On November 25, 2025, the Stochastic Oscillator for ZYXI moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 68 instances where the indicator left the oversold zone. In of the 68 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The Momentum Indicator moved above the 0 level on November 26, 2025. You may want to consider a long position or call options on ZYXI as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ZYXI just turned positive on November 26, 2025. Looking at past instances where ZYXI's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .
Following a +11 3-day Advance, the price is estimated to grow further. Considering data from situations where ZYXI advanced for three days, in of 253 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for ZYXI moved out of overbought territory on November 28, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
ZYXI moved below its 50-day moving average on December 02, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZYXI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ZYXI broke above its upper Bollinger Band on November 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ZYXI entered a downward trend on November 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ZYXI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.569) is normal, around the industry mean (9.433). P/E Ratio (24.778) is within average values for comparable stocks, (30.333). ZYXI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.576). Dividend Yield (0.000) settles around the average of (0.029) among similar stocks. P/S Ratio (0.333) is also within normal values, averaging (141.603).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZYXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
a distributor of medical devices
Industry MedicalDistributors
A.I.dvisor tells us that ZYXI and HSIC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZYXI and HSIC's prices will move in lockstep.
| Ticker / NAME | Correlation To ZYXI | 1D Price Change % | ||
|---|---|---|---|---|
| ZYXI | 100% | -0.85% | ||
| HSIC - ZYXI | 31% Poorly correlated | +1.69% | ||
| GEG - ZYXI | 11% Poorly correlated | -0.76% | ||
| OMI - ZYXI | 11% Poorly correlated | -2.99% | ||
| AMFPF - ZYXI | 10% Poorly correlated | N/A | ||
| SHTDY - ZYXI | 9% Poorly correlated | +0.03% | ||
More | ||||